Voluntary Antibiotic Recall Initiated

Article

Three lots of ertapenem, (Invanz) 1g (0803930, 0803940, and 0803950), a Merck antibiotic that is indicated for the treatment of patients with moderate to severe infections, were recalled because of two incidents of broken glass found in the reconstituted solution for injection [more].

Three lots of ertapenem, (Invanz) 1g (0803930, 0803940, and 0803950), a Merck antibiotic that is indicated for the treatment of patients with moderate to severe infections, were recalled because of two incidents of broken glass found in the reconstituted solution for injection. Healthcare professionals are advised to immediately stop dispensing all products from the three lots specified above. All lots have an expiration date of October 2008, and no other lots were affected by this recall. Medical questions about the recall can be directed to Merck’s national service center at 800–672–6372.

Recent Videos
Russell Libby, MD, FAAP
Greg Forlenza, MD
Lawrence Eichenfield, MD
Nathan Kuppermann, MD, MPH
COVID-19 Roundtable: Considering off label therapies
Greg Forlenza, MD
Greg Forlenza, MD
COVID-19 Therapy Roundtable: Focusing on Inpatient Care | Image credit: Production Perig
Image credit: Production Perig
© 2025 MJH Life Sciences

All rights reserved.